Global Canine Flu Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2024

  • receipt Report ID : 158870
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 108
  • list Pharmaceuticals and Healthcare

Canine flu, which is also called dog flu; is a contagious disease that affects the dog’s respiratory system. It is mainly caused by canine influenza virus/Type An influenza virus. There are two types of influenza viruses H3N2 virus H3N8 virus.

Scope of the Report:

This report studies the Canine Flu Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Canine Flu Therapeutics market by product type and applications/end industries.

The global Canine Flu Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Canine Flu Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Merck & Co

Intervet

Zoetis Services

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Vaccines

Anti-inflammatory Drugs

Antibiotics

Others

Market Segment by Applications, can be divided into

Vet Clinics

Veterinary Hospitals

Animal Healthcare Facilities

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Canine Flu Therapeutics Market Overview

1.1 Product Overview and Scope of Canine Flu Therapeutics

1.2 Classification of Canine Flu Therapeutics by Types

1.2.1 Global Canine Flu Therapeutics Revenue Comparison by Types (2017-2023)

1.2.2 Global Canine Flu Therapeutics Revenue Market Share by Types in 2017

1.2.3 Vaccines

1.2.4 Anti-inflammatory Drugs

1.2.5 Antibiotics

1.2.6 Others

1.3 Global Canine Flu Therapeutics Market by Application

1.3.1 Global Canine Flu Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Vet Clinics

1.3.3 Veterinary Hospitals

1.3.4 Animal Healthcare Facilities

1.4 Global Canine Flu Therapeutics Market by Regions

1.4.1 Global Canine Flu Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Canine Flu Therapeutics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Canine Flu Therapeutics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Canine Flu Therapeutics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Canine Flu Therapeutics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Canine Flu Therapeutics Status and Prospect (2013-2023)

1.5 Global Market Size of Canine Flu Therapeutics (2013-2023)

2 Manufacturers Profiles

2.1 Merck & Co

2.1.1 Business Overview

2.1.2 Canine Flu Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Merck & Co Canine Flu Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Intervet

2.2.1 Business Overview

2.2.2 Canine Flu Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Intervet Canine Flu Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.3 Zoetis Services

2.3.1 Business Overview

2.3.2 Canine Flu Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Zoetis Services Canine Flu Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Canine Flu Therapeutics Market Competition, by Players

3.1 Global Canine Flu Therapeutics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Canine Flu Therapeutics Players Market Share

3.2.2 Top 10 Canine Flu Therapeutics Players Market Share

3.3 Market Competition Trend

4 Global Canine Flu Therapeutics Market Size by Regions

4.1 Global Canine Flu Therapeutics Revenue and Market Share by Regions

4.2 North America Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

4.3 Europe Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

4.5 South America Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

5 North America Canine Flu Therapeutics Revenue by Countries

5.1 North America Canine Flu Therapeutics Revenue by Countries (2013-2018)

5.2 USA Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

5.3 Canada Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

5.4 Mexico Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

6 Europe Canine Flu Therapeutics Revenue by Countries

6.1 Europe Canine Flu Therapeutics Revenue by Countries (2013-2018)

6.2 Germany Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

6.3 UK Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

6.4 France Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

6.5 Russia Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

6.6 Italy Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Canine Flu Therapeutics Revenue by Countries

7.1 Asia-Pacific Canine Flu Therapeutics Revenue by Countries (2013-2018)

7.2 China Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

7.3 Japan Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

7.4 Korea Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

7.5 India Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

8 South America Canine Flu Therapeutics Revenue by Countries

8.1 South America Canine Flu Therapeutics Revenue by Countries (2013-2018)

8.2 Brazil Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

8.3 Argentina Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

8.4 Colombia Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Canine Flu Therapeutics by Countries

9.1 Middle East and Africa Canine Flu Therapeutics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

9.3 UAE Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

9.4 Egypt Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

9.6 South Africa Canine Flu Therapeutics Revenue and Growth Rate (2013-2018)

10 Global Canine Flu Therapeutics Market Segment by Type

10.1 Global Canine Flu Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Global Canine Flu Therapeutics Market Forecast by Type (2018-2023)

10.3 Vaccines Revenue Growth Rate (2013-2023)

10.4 Anti-inflammatory Drugs Revenue Growth Rate (2013-2023)

10.5 Antibiotics Revenue Growth Rate (2013-2023)

10.6 Others Revenue Growth Rate (2013-2023)

11 Global Canine Flu Therapeutics Market Segment by Application

11.1 Global Canine Flu Therapeutics Revenue Market Share by Application (2013-2018)

11.2 Canine Flu Therapeutics Market Forecast by Application (2018-2023)

11.3 Vet Clinics Revenue Growth (2013-2018)

11.4 Veterinary Hospitals Revenue Growth (2013-2018)

11.5 Animal Healthcare Facilities Revenue Growth (2013-2018)

12 Global Canine Flu Therapeutics Market Size Forecast (2018-2023)

12.1 Global Canine Flu Therapeutics Market Size Forecast (2018-2023)

12.2 Global Canine Flu Therapeutics Market Forecast by Regions (2018-2023)

12.3 North America Canine Flu Therapeutics Revenue Market Forecast (2018-2023)

12.4 Europe Canine Flu Therapeutics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Canine Flu Therapeutics Revenue Market Forecast (2018-2023)

12.6 South America Canine Flu Therapeutics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Canine Flu Therapeutics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Canine Flu Therapeutics Picture

Table Product Specifications of Canine Flu Therapeutics

Table Global Canine Flu Therapeutics and Revenue (Million USD) Market Split b

Please fill the form below, to recieve the report sample


+1